SAN JOSE, Calif., April 27, 2026 (GLOBE NEWSWIRE)-- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in ...

Outset Medical has raised $76.5 million in a series C round led by T. Rowe Price Associates. In addition to new investor T. Rowe Price Associates, existing investors Fidelity Management & Research ...

SAN JOSE, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis ...

Outset said that it has resumed distribution of TabloCart with prefiltration and has product available to ship to customers in the United States. “With the FDA’s clearance of TabloCart with ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener The latest update ...

Outset Medical is set to release its financial results for Q4 and full-year 2024, which could indicate positive growth following the launch of their innovative Tablo® Hemodialysis System. The upcoming ...

Warburg Pincus’ decade-long investment in a business looking to redefine kidney dialysis care is proving a home run for the private equity firm. Following Outset Medical’s $242 million IPO on Tuesday, ...

SAN JOSE, Calif., May 07, 2026 (GLOBE NEWSWIRE)-- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, a commercial-stage company delivering first-of-its-kind technology into the growing global dialysis market, today announced the appointment of two ...

Outset Medical (NASDAQ:OM), the innovator behind the Tablo Hemodialysis System, reported fourth-quarter earnings on Wednesday, Feb. 19, that topped analysts' consensus expectations on top and bottom ...